Ingersoll Rand (IR) Reports Next Week: Wall Street Expects Earnings Growth

Ingersoll (IR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • Feb 5, 2026

Ingersoll (IR) Surges 5.4%: Is This an Indication of Further Gains?

Ingersoll (IR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Zacks Investment Research • Feb 4, 2026

Ingersoll Rand to Participate in Upcoming Investor Conferences

DAVIDSON, N.C., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vik Kini, chief financial officer, will participate in fireside chats at the following upcoming investor conferences:

GlobeNewsWire • Jan 27, 2026

Ingersoll Rand Inc. (IR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Ingersoll Rand Inc. (IR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seeking Alpha • Jan 14, 2026

Ingersoll Rand Schedules Fourth Quarter 2025 Earnings Release and Conference Call

DAVIDSON, N.C., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, will issue its fourth quarter 2025 earnings release after the market closes on Thursday, February 12, 2026.

GlobeNewsWire • Jan 12, 2026

Ingersoll Rand Acquires Scinomix, Strengthens Life Sciences Portfolio

IR strengthens its life sciences platform by acquiring Scinomix, adding automation workflow technologies for labs and pharma markets.

Zacks Investment Research • Jan 6, 2026

Ingersoll Rand Expands Life Sciences Capabilities with Acquisition of Scinomix, Inc.

DAVIDSON, N.C., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc., (NYSE: IR) a global provider of mission-critical flow creation and life science and industrial solutions, has acquired Scinomix, Inc., expanding the company's life sciences portfolio.

GlobeNewsWire • Jan 5, 2026

Ingersoll Rand to Present at the 44th Annual J.P. Morgan Healthcare Conference

DAVIDSON, N.C., Dec. 22, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life science and industrial solutions, announced that Vicente Reynal, chairman and chief executive officer, Vik Kini, chief financial officer, and Scott Watson, senior vice president and general manager, Life Science Technologies, will present at the 2026 J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026, at 7:30 a.m. Pacific Time.

GlobeNewsWire • Dec 22, 2025

Ingersoll Rand Welcomes Jerome Guillen to Board of Directors

DAVIDSON, N.C., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Ingersoll Rand Inc. (NYSE: IR), a global provider of mission-critical flow creation and life sciences and industrial solutions, today announced the appointment of Jerome Guillen to its Board of Directors, effective January 1, 2026.

GlobeNewsWire • Dec 17, 2025

Here's Why You Should Retain Ingersoll Rand in Your Portfolio

IR sees order growth and acquisitions lift 2025 outlook, while cash flow supports buybacks despite rising costs.

Zacks Investment Research • Dec 15, 2025